FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061393768> ?p ?o ?g. }

• W2061393768 endingPage "726" @default.
• W2061393768 startingPage "718" @default.
• W2061393768 abstract "Atherosclerotic coronary heart disease (CHD) continues to be the dominant disease in Western society. A large body of evidence directly linking serum cholesterol levels and CHD risk has stimulated population treatment strategies designed to reduce cholesterol and CHD risk. Data indicating a relation between low cholesterol and non-CHD risk have, however, suggested that cholesterol reduction may not always be desirable. The primary goal of this evaluative review of the available evidence was to answer the following question: Is prevention/regression therapy for CHD safe and effective?Three lines of evidence were reviewed: epidemiologic studies; primary and secondary prevention trials with clinical end points; and secondary prevention trials with quantitative coronary angiography as a surrogate end point for clinical CHD.Original studies and meta-analyses were reviewed. The principal selection criteria for the epidemiologic studies were large size and prolonged follow-up; for the trials, randomization and viable clinical (CHD events, CHD mortality, total mortality) or angiographic end points.The data were initially extracted by a single reviewer using common qualitative guidelines. The data were then evaluated by all authors acting as a data interpretation team.Overall, the epidemiologic data revealed excess risk of fatal and nonfatal CHD events was directly related to total cholesterol and low-density lipoprotein (LDL) cholesterol levels, for both men and women and for both younger (< 65 years) and older (> or = 65 years) patients, over a wide range of serum cholesterol levels. The predictive value was higher in younger men than older men and women, although part of this quantitative interaction may be due to fewer studies, with fewer end points, in the older and female populations. The CHD events and CHD mortality, but not total mortality, were consistently reduced in trials of cholesterol-lowering therapy. The regression trials, predominantly in CHD patients with high cholesterol values (mean 7.1 mmol/L), demonstrated improvement in angiographic atherosclerosis in every study. The evidence for elevated risk of non-CHD death at very low levels of cholesterol is uncertain and controversial. The most likely possibilities for this apparent relationship are unknown confounding variables and the play of chance.Serum cholesterol levels are directly associated with CHD risk, and there is no threshold level below which there is no risk. Reduction of high serum cholesterol levels reduces CHD risk. Whether lipid-lowering and adjunctive antiatherosclerotic therapies are effective and safe in the majority of CHD patients who have desirable or borderline cholesterol levels remains undetermined." @default.
• W2061393768 created "2016-06-24" @default.
• W2061393768 creator A5012706547 @default.
• W2061393768 creator A5017902770 @default.
• W2061393768 creator A5026416559 @default.
• W2061393768 creator A5041222213 @default.
• W2061393768 creator A5077801809 @default.
• W2061393768 creator A5087339027 @default.
• W2061393768 date "1994-03-01" @default.
• W2061393768 modified "2023-10-17" @default.
• W2061393768 title "Prevention and Regression of Coronary Atherosclerosis" @default.
• W2061393768 cites W1549654956 @default.
• W2061393768 cites W1845185826 @default.
• W2061393768 cites W1848464647 @default.
• W2061393768 cites W1984058728 @default.
• W2061393768 cites W1984549933 @default.
• W2061393768 cites W1985494679 @default.
• W2061393768 cites W1988798359 @default.
• W2061393768 cites W1990132316 @default.
• W2061393768 cites W1992831204 @default.
• W2061393768 cites W2001802117 @default.
• W2061393768 cites W2003844753 @default.
• W2061393768 cites W2004145281 @default.
• W2061393768 cites W2004388218 @default.
• W2061393768 cites W2007316570 @default.
• W2061393768 cites W2014575233 @default.
• W2061393768 cites W2028693103 @default.
• W2061393768 cites W2029833995 @default.
• W2061393768 cites W2053235682 @default.
• W2061393768 cites W2058769762 @default.
• W2061393768 cites W2059686465 @default.
• W2061393768 cites W2063757920 @default.
• W2061393768 cites W2067006561 @default.
• W2061393768 cites W2069445171 @default.
• W2061393768 cites W2071483128 @default.
• W2061393768 cites W2073081093 @default.
• W2061393768 cites W2076388691 @default.
• W2061393768 cites W2077760013 @default.
• W2061393768 cites W2082768646 @default.
• W2061393768 cites W2085709114 @default.
• W2061393768 cites W2087375731 @default.
• W2061393768 cites W2087887738 @default.
• W2061393768 cites W2089648098 @default.
• W2061393768 cites W2132942256 @default.
• W2061393768 cites W2143465004 @default.
• W2061393768 cites W2145799136 @default.
• W2061393768 cites W2148695849 @default.
• W2061393768 cites W2312388685 @default.
• W2061393768 cites W2324712847 @default.
• W2061393768 cites W2331959986 @default.
• W2061393768 cites W2341665659 @default.
• W2061393768 cites W2469805673 @default.
• W2061393768 cites W2585382523 @default.
• W2061393768 cites W2725187802 @default.
• W2061393768 cites W4205376562 @default.
• W2061393768 cites W4233889328 @default.
• W2061393768 cites W4240553663 @default.
• W2061393768 cites W4254363271 @default.
• W2061393768 cites W4296883165 @default.
• W2061393768 cites W4298694985 @default.
• W2061393768 cites W4376849644 @default.
• W2061393768 doi "https://doi.org/10.1378/chest.105.3.718" @default.
• W2061393768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8131532" @default.
• W2061393768 hasPublicationYear "1994" @default.
• W2061393768 type Work @default.
• W2061393768 sameAs 2061393768 @default.
• W2061393768 citedByCount "12" @default.
• W2061393768 crossrefType "journal-article" @default.
• W2061393768 hasAuthorship W2061393768A5012706547 @default.
• W2061393768 hasAuthorship W2061393768A5017902770 @default.
• W2061393768 hasAuthorship W2061393768A5026416559 @default.
• W2061393768 hasAuthorship W2061393768A5041222213 @default.
• W2061393768 hasAuthorship W2061393768A5077801809 @default.
• W2061393768 hasAuthorship W2061393768A5087339027 @default.
• W2061393768 hasConcept C107130276 @default.
• W2061393768 hasConcept C126322002 @default.
• W2061393768 hasConcept C141341695 @default.
• W2061393768 hasConcept C164705383 @default.
• W2061393768 hasConcept C203092338 @default.
• W2061393768 hasConcept C2778163477 @default.
• W2061393768 hasConcept C2908647359 @default.
• W2061393768 hasConcept C535046627 @default.
• W2061393768 hasConcept C71924100 @default.
• W2061393768 hasConcept C99454951 @default.
• W2061393768 hasConceptScore W2061393768C107130276 @default.
• W2061393768 hasConceptScore W2061393768C126322002 @default.
• W2061393768 hasConceptScore W2061393768C141341695 @default.
• W2061393768 hasConceptScore W2061393768C164705383 @default.
• W2061393768 hasConceptScore W2061393768C203092338 @default.
• W2061393768 hasConceptScore W2061393768C2778163477 @default.
• W2061393768 hasConceptScore W2061393768C2908647359 @default.
• W2061393768 hasConceptScore W2061393768C535046627 @default.
• W2061393768 hasConceptScore W2061393768C71924100 @default.
• W2061393768 hasConceptScore W2061393768C99454951 @default.
• W2061393768 hasIssue "3" @default.
• W2061393768 hasLocation W20613937681 @default.
• W2061393768 hasLocation W20613937682 @default.
• W2061393768 hasOpenAccess W2061393768 @default.

• next